Press Releases

Computational biologist Thomas Norman, PhD, of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) has been named one of 53 recipients of the prestigious 2020 National Institutes of Health (NIH) Director’s New Innovator Award. As part of the award, Dr. Norman will receive $1.5 million in direct costs upfront in the first year of a five-year award. 

To recognize the beginning of Breast Cancer Awareness Month, MSK shared five tips to help women navigate the prevention, diagnosis, and treatment of breast cancer during the COVID-19 global health crisis.

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing.

MSK is proud to return as a participant in the 4th Annual Black Health Matters Virtual Summit. Black Health Matters Virtual Summit will provide attendees a chance to interact with physicians, scientists, and advocates, including former First Lady, Michelle Obama, to address equity in all areas of health.

MSK announces the establishment of the Marie-Josée Kravis Women in Science Endeavor (WiSE) to provide financial and professional support to women scientists pursuing biomedical research at MSK, pledging its commitment to gender equity in science and paving the way for more women to become leaders in their field.

According to a new study from Memorial Sloan Kettering published June 24 in Nature Medicine, patients in active cancer treatment who develop COVID-19 infection don’t fare any worse than other hospitalized patients. Researchers say their findings suggest that no one should delay cancer treatment because of concerns about the virus.